復旦張江(01349.HK)兩名董事減持約800萬股A股
復旦張江(01349.HK)(688505.SH)公佈,2021年7月21日,公司披露《關於部分董事、高級管理人員集中競價減持股份計劃的公告》,董事、副總經理蘇勇及董事、副總經理趙大君擬通過集中競價方式各減持不超過400萬股,各不超過公司總股本比例0.38%。
目前蘇勇減持股份數量共計399.5萬股,佔總股本的0.38%,減持價格區間爲13.78元至15元,總金額5,712.45萬元人民幣(下同);趙大君減持400萬股,佔總股本的0.38%,減持價格區間爲14.02元至14.35元,涉總金額5,665.68萬元。上述減持計劃實施完畢,減持計劃完成後,蘇勇持股數量爲1,831.79萬股,佔總股本的1.76%;趙大君持股爲1,526.07萬股,佔總股本的1.46%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.